Catalogo dei prodotti della ricerca
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishLevothyroxine (T4) is a critical-dose drug, because little variations in the blood concentration may cause treatment failure as well as iatrogenic thyrotoxicosis. Despite the dose response of this drug being more carefully titrated nowadays, several papers still report that a significant fraction of patients treated with levothyroxine demonstrate a TSH which is not on target. Moreover, some widespread gastrointestinal disorders as well as interfering drugs and foods may cause the “refractoriness” of a significant number of patients to an expected dose of thyroxine. The increasing awareness of the mechanisms interfering with the oral thyroid hormone bioavailability and the body of evidence regarding the complexity of treatment in certain classes of patients prompted pharmaceutical research to identify new hormonal formulations to optimize the performance of this drug. In this brief review, the progression of the scientific knowledge of novel T4 formulations use has been analyzed.
Novel thyroxine formulations. A further step toward precision medicine / Virili, Camilla; Pierpaolo, Trimboli; Centanni, Marco. - In: ENDOCRINE. - ISSN 1559-0100. - 1:66(2019), pp. 87-94.
| Titolo: | Novel thyroxine formulations. A further step toward precision medicine | |
| Autori: | CENTANNI, Marco (Corresponding author) | |
| Data di pubblicazione: | 2019 | |
| Rivista: | ||
| Citazione: | Novel thyroxine formulations. A further step toward precision medicine / Virili, Camilla; Pierpaolo, Trimboli; Centanni, Marco. - In: ENDOCRINE. - ISSN 1559-0100. - 1:66(2019), pp. 87-94. | |
| Handle: | http://hdl.handle.net/11573/1449136 | |
| Appartiene alla tipologia: | 01g Articolo di rassegna (Review) |
File allegati a questo prodotto
| File | Note | Tipologia | Licenza | |
|---|---|---|---|---|
| Virili_Novel-thyroxine-formulations_2019.pdf | Versione editoriale (versione pubblicata con il layout dell'editore) | Tutti i diritti riservati (All rights reserved) | Administrator Richiedi una copia |
Copyright © 2022